• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

bioAffinity Technologies, Inc. - Common Stock (NQ:BIAF)

1.290 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 142,840
Open 1.310
Bid (Size) 1.300 (200)
Ask (Size) 1.410 (1,000)
Prev. Close 1.290
Today's Range 1.290 - 1.470
52wk Range 1.110 - 46.53
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation
January 07, 2026
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable
December 03, 2025
From bioAffinity Technologies, Inc.
Via Business Wire

Performance

YTD
+5.7%
+5.7%
1 Month
-21.8%
-21.8%
3 Month
-57.7%
-57.7%
6 Month
-87.4%
-87.4%
1 Year
-95.5%
-95.5%

More News

Read More
News headline image
bioAffinity Technologies Reports Third Quarter 2025 Financial Results
November 14, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume
November 05, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases
October 28, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025
October 20, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
Why Did bioAffinity Technologies' Stock Slip In After-Hours Trading After A Big Day Of Gains? ↗
October 17, 2025
Via Benzinga
Topics Intellectual Property
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
October 16, 2025
Via Benzinga
News headline image
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer
October 16, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
October 15, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
October 09, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
October 08, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
October 08, 2025
Via Chartmill
News headline image
What's Driving bioAffinity Technologies' Big Pre-Market Surge? ↗
October 08, 2025
Via Benzinga
News headline image
bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025
October 07, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Announces Closing of $4.8 Million Public Offering
September 30, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
Energy Fuels, Firefly Aerospace And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
September 30, 2025
Via Benzinga
News headline image
Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket ↗
September 30, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
September 29, 2025
Via Benzinga
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
September 29, 2025
Via Chartmill
News headline image
bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering
September 29, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
September 29, 2025
Via Benzinga
News headline image
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket ↗
September 29, 2025
Via Benzinga
News headline image
bioAffinity Technologies Soars on Breakthrough Lung Cancer Diagnostic Data
September 26, 2025
Via MarketMinute
Topics Death
News headline image
Keep an eye on the top gainers and losers in Friday's session. ↗
September 26, 2025
Via Chartmill

Frequently Asked Questions

Is bioAffinity Technologies, Inc. - Common Stock publicly traded?
Yes, bioAffinity Technologies, Inc. - Common Stock is publicly traded.
What exchange does bioAffinity Technologies, Inc. - Common Stock trade on?
bioAffinity Technologies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for bioAffinity Technologies, Inc. - Common Stock?
The ticker symbol for bioAffinity Technologies, Inc. - Common Stock is BIAF on the Nasdaq Stock Market
What is the current price of bioAffinity Technologies, Inc. - Common Stock?
The current price of bioAffinity Technologies, Inc. - Common Stock is 1.290
When was bioAffinity Technologies, Inc. - Common Stock last traded?
The last trade of bioAffinity Technologies, Inc. - Common Stock was at 01/07/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap